Dechra Pharmaceuticals plc 3.4% Potential Upside Indicated by HSBC

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Dechra Pharmaceuticals plc with EPIC/TICKER (LON:DPH) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ this morning by analysts at HSBC. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. HSBC have set a target price of 2950 GBX on its stock. This indicates the analyst now believes there is a potential upside of 3.4% from today’s opening price of 2852 GBX. Over the last 30 and 90 trading days the company share price has increased 240 points and decreased 116 points respectively. The 1 year high stock price is 3080 GBX while the 52 week low for the stock is 2020 GBX.

Dechra Pharmaceuticals plc has a 50 day moving average of 2,711.22 GBX and the 200 Day Moving Average price is recorded at 2,761.18. There are currently 102,815,242 shares in issue with the average daily volume traded being 268,274. Market capitalisation for LON:DPH is £2,862,376,337 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search